GTM EXOMELA® Exosome Skin Booster | GTM Cosmetics (South Korea)

Short Description

An advanced, two-part regenerative and brightening skin booster system pairing lyophilized EXO Signal 1000 Exosome Powder with Mela Vital Solution (5 mL). Formulated with purified stem cell/fibroblast-derived exosomes, Salmon PDRN, Tranexamic Acid, Glutathione, and Hyaluronic Acid, GTM EXOMELA® targets melasma, stubborn post-inflammatory hyperpigmentation (PIH), photoaging, and cellular senescence—accelerating tissue turnover, suppressing melanogenesis, and restoring luminous dermal clarity.

Detailed Description

GTM EXOMELA® (EXO Mela) is a professional-grade dual-phase exosome skin booster manufactured in South Korea by GTM Cosmetics / C-MED Global. Designed specifically to address hyperpigmentation and chronological skin fatigue simultaneously, it merges targeted nano-vesicular cellular signaling with established depigmenting and regenerative bio-actives.

The system functions through a synergistic two-vial reconstitution protocol:

1. Vial 1: EXO Signal 1000 Lyophilized Powder: Contains freeze-dried extracellular vesicles (exosomes) derived from stem cell/fibroblast conditioned media. These nano-sized carriers (~30–150 nm) penetrate target cell membranes to deliver regenerative microRNAs, messenger RNAs, and biological growth factors directly into fibroblasts and keratinocytes. This signal stimulates rapid cell turnover, repairs UV-damaged cell structures, and downregulates pro-inflammatory cytokines that exacerbate pigmentary disorders.

2. Vial 2: Mela Vital Solution (5 mL Activator): A concentrated liquid matrix formulated to reconstitute the exosome powder while delivering targeted depigmenting and structural nutrients:

   • Tranexamic Acid (TXA): Blocks the interaction of melanocytes and keratinocytes by inhibiting the plasminogen/plasmin pathway, suppressing UV-induced tyrosinase activation and vascular-driven melasma.

   • PDRN (Polydeoxyribonucleotide): Salmon-derived DNA fragments that activate cell-surface Adenosine $A_{2A}$ receptors, supplying nucleotides for DNA repair and accelerating tissue re-epithelialization.

   • Glutathione: Neutralizes intracellular free radicals and drives the conversion of eumelanin (dark pigment) into pheomelanin (light pigment), clearing sallow and dull undertones.

   • High-Purity Sodium Hyaluronate (HA): Re-establishes hydration reservoirs in the extracellular matrix, restoring moisture balance and skin elasticity.

Treatment Areas & Indications

• Pigmentary Disorders & Uneven Complexion:

  • Epidermal and mixed-type melasma resistant to topical hydroquinone or standard peels

  • Post-inflammatory hyperpigmentation (PIH) secondary to acne or invasive aesthetic procedures

  • Solar lentigines, sun spots, and photo-damaged mottled pigmentation

  • Chronically dull, sallow, and devitalized skin tones

• Cellular Rejuvenation & Texture Refinement:

  • Superficial dynamic and static rhytids, fine dehydration lines, and elastosis

  • Enlarged pore diameter and uneven skin surface micro-relief

  • Thinning dermal envelope and compromised cutaneous elasticity

• Tissue Repair & Post-Procedure Synergy:

  • Prevention of rebound hyperpigmentation following Picosecond/Q-switched lasers, fractional RF, and chemical peeling

  • Calming erythema and speeding re-epithelialization after ablative and non-ablative resurfacing

Key Clinical Advantages

• Intact Exosome Potency via Lyophilization: Freeze-drying the exosome fraction protects delicate signaling proteins and nucleic acids from degradation, ensuring full biological activity upon chairside reconstitution.

• Dual Regenerative & Pigment-Targeting Cascade: Simultaneously repairs the extracellular matrix while interrupting multiple enzymatic steps in the melanogenesis pathway.

• Vascular-Melasma Resolution: Tranexamic acid dampens underlying microvascular hyperactivity, addressing the vascular erythema component commonly seen in chronic melasma.

• Broad In-Clinic Versatility: Designed for transdermal micro-channeling (MTS / automated microneedling pens), fractional RF post-infusion, electroporation, or targeted micro-papular mesotherapy protocols.

• Minimal Downtime Profile: High concentrations of PDRN and exosome signaling factors suppress acute neurogenic inflammation, calming procedure-related erythema and reducing recovery time.

Technical Specifications

Professional Advisory: GTM EXOMELA® is a professional-grade aesthetic solution formulated strictly for credentialed dermatologists, plastic surgeons, and aesthetic practitioners trained in transdermal drug delivery and microneedling protocols. It is not formulated for intravenous, intra-arterial, or deep bolus structural tissue placement.